NDC 0078-0569

EXTAVIA

Interferon Beta-1b

EXTAVIA is a Kit in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is .

• Product ID: 0078-0569_171d9146-83a2-42d5-956c-08167448397c
• NDC: 0078-0569
• Product Type: Human Prescription Drug
• Proprietary Name: EXTAVIA
• Generic Name: Interferon Beta-1b
• Dosage Form: Kit
• Marketing Start Date: 2009-08-14
• Marketing Category: BLA / BLA
• Application Number: BLA125290
• Labeler Name: Novartis Pharmaceuticals Corporation
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0078-0569-12

15 BLISTER PACK in 1 CARTON (0078-0569-12) > 1 KIT in 1 BLISTER PACK (0078-0569-61) * 3 mL in 1 VIAL, SINGLE-USE * 1.2 mL in 1 SYRINGE

• Marketing Start Date: 2009-08-14
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0078-0569-61 [00078056961]

EXTAVIA KIT

• Marketing Category: BLA
• Application Number: BLA125290
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2012-08-13

NDC 0078-0569-12 [00078056912]

EXTAVIA KIT

• Marketing Category: BLA
• Application Number: BLA125290
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2009-08-14

Drug Details

OpenFDA Data

• SPL SET ID: 4cfdb571-ec4c-478f-bedc-e0669eeea504
• Manufacturer:
  • Novartis Pharmaceuticals Corporation
• RxNorm Concept Unique ID - RxCUI:
  • 198360
  • 860244

NDC Crossover Matching brand name "EXTAVIA" or generic name "Interferon Beta-1b"

NDC	Brand Name	Generic Name
0078-0569	EXTAVIA	Interferon beta-1b
50419-524	Betaseron	interferon beta-1b